Management of diabetes in COPD should follow treatment guidelines for type 2 diabetes. However oral hypoglycaemic treatment may need to be modified in those with respiratory failure, cachexia or heart failure. Glucose tolerance deteriorates during COPD exacerbations due to physiological stress of acute ...
Not all patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) benefit from treatment with systemic corticosteroids and antibiotics. The aim of the study was to identify criteria recommended in current COPD guidelines for treating acute exacerbations with systemic corticosteroids an...
while the importance of traditional cardiovascular risk factors and the optimisation of treatment for cardiovascular diseases according to their guidelines is acknowledged, here we will primarily focus on the influence
Inspiratory capacity (IC) may be helpful in assessing severity, prognosis and response to treatment of airway obstruction. Worsening obstruction and alteration in the elastic properties of the lungs of patients with COPD are associated with the development of progressive lung hyperinflation and decline ...
obstruction as cases, a finding interpreted as error because the intent was to find the more severe, high-risk patients.1 Upon further reflection, we questioned whether these "misclassified" cases may represent an additional group of patients who might also benefit from diagnosis and treatment. Al...
“An important thing to take away about asthma management is that inhaled corticosteroid treatment is by far the first line therapy for patients with asthma and our goal is symptom free and normal pulmonary function tests,” she said. The least a...
Asthma and chronic obstructive pulmonary disease (COPD) are disorders of airway inflammation that are characterized by airflow obstruction. These disease entities demonstrate similar spirometric characteristics including FEV1/FVC <70 % and FEV1 <80 %, wi
obstruction as cases, a finding interpreted as error because the intent was to find the more severe, high-risk patients.1 Upon further reflection, we questioned whether these "misclassified" cases may represent an additional group of patients who might also benefit from diagnosis and treatment. Al...
The GOLD and NICE guidelines both do not recommend using methylxanthines in patients with COPD exacerbations [5,52]. Future of Bronchodilators in COPD Exacerbations Bronchodilators are considered a mainstay of treatment for patients with COPD. While these drugs play a central role in maintenance ...